In a landmark decision that will reshape how we approach obesity treatment worldwide, the World Health Organization1 has released its first-ever clinical guidelines recommending GLP-1 therapies for adults living with obesity. This isn’t merely another drug approval or incremental policy update; it represents a transformation in how the world’s leading health authority understands and addresses a condition affecting over 1 billion people globally.
Similar Posts
Natural Way of Excellent Health Care
Measles was one considered a disease that was completely eliminated, thanks to modern science. And now,…
Your Broccoli, Potatoes & Citrus May Soon Contain PFAS — How To Protect Yourself
The EPA greenlit isocycloseram for agricultural use on crops including potatoes, citrus fruits, tomatoes, almonds, peas,…
Purna Supto Bajrasana And ArdhaKurmasana
Purna Supto Bajrasana A. Method – Sit in Bajrasana. Stand with your knees bent. Lean back…
FDA Will Remove Warnings for HRT Products Used for Menopause
The Food and Drug Administration will remove black box warnings from hormone replacement therapy (HRT) products,…
How Do We Ensure Digital Mental Health Solutions Reach Underserved Youth?
Digital solutions have greatly expanded access to mental health support, though they’re not always reaching the…
Public health warning: tablets sold as MDMA (Ecstasy) found to contain a potent opioid
NSW Health is warning of the dangers of tablets which are being sold as MDMA (ecstasy)…
